概括
林氏素和红色素显示对抗抗性葡萄球菌菌株的对抗性. 红素改变了细菌的新陈代谢,增加了林氏.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 葡萄球菌菌株可以对抗生素,如红菌素,产生耐药性.
- 了解药物相互作用对于有效的抗微生物治疗至关重要.
研究的目的:
- 为了研究林氏素和红色素在Staphylococcus菌株之间的相互作用.
- 确定这两种抗生素之间的对抗机制.
主要方法:
- 使用抗红红素但对林氏素敏感的葡萄球菌菌株进行阿格拉扩散试验.
- 在有红色素的情况下确定林氏素的最小抑制度 (MICs).
主要成果:
- 在林氏素和红色素之间观察到对抗作用.
- 红素显著增加了林氏素的最小抑制度.
- 这种对抗性似乎源于红色素诱导的细菌代谢变化,而不是直接的药物相互作用.
结论:
- 红素对抗红素活性对抗红素耐药的葡萄球菌.
- 改变细菌代谢是这种观察到的药物对抗的可能机制.
- 这些发现对治疗耐药葡萄球菌菌株引起的感染有潜在的临床影响.
关键词:
抗生素是一种抗生素.药物耐药性,微生物耐药性皮质红菌是什么 皮质红菌是什么实验室研究实验室研究林科米奇尼 (LINCOMYCIN) 是一个药理学 在药理学方面.这是一种STAPHYLOCOCCUSUS.更多相关视频
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
相关概念视频
Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
